Veralox Therapeutics Sitemap
Pages
Posts by category
- Category: Company News and Events
- Veralox Therapeutics Appoints Lisa Beck as Chief Business Officer
- Veralox Therapeutics Appoints Michael Hanna As Chief Medical Officer
- Veralox Therapeutics Announces Closing Of $16.6 Million Series A Financing And Announces New Board Members
- Veralox Therapeutics Announces FDA Orphan Drug Designation for VLX-1005
- Veralox Therapeutics Announces IND Submission for VLX-1005 to Treat Heparin-Inducted Thrombocytopenia
- Veralox Therapeutics Appoints Life Sciences Industry Veteran Alex Martin as Chairman of the Board of Directors
- Veralox Therapeutics Raises $5.4 Million in Seed Funding Co-Led by JDRF T1D Fund and Sanofi Ventures
- Biotech Startups On the Rise in Frederick, Maryland
- Frederick Innovative Technology Center, Inc. – Success Story
- Meet Our Clients: Jeff Strovel, CEO of VERALOX Therapeutics